Why Randomize in Clinical Trials?

Barbosa, Jose; Connett, John; Ramsay, Robert

doi:10.2337/diacare.6.1.101

Article navigation

Letters to the Editor| January 01 1983

Why Randomize in Clinical Trials?

Jose Barbosa;

Jose Barbosa

Departments of Medicine and Ophthalmology, and Division of Biometry, University of Minnesota

Minneapolis, Minnesota

Search for other works by this author on:

This Site

PubMed

Google Scholar

John Connett;

John Connett

Departments of Medicine and Ophthalmology, and Division of Biometry, University of Minnesota

Minneapolis, Minnesota

Search for other works by this author on:

This Site

PubMed

Google Scholar

Robert Ramsay

Departments of Medicine and Ophthalmology, and Division of Biometry, University of Minnesota

Minneapolis, Minnesota

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address reprint requests to Jose Barbosa, M.D., Department of Medicine, Box 716 Mayo Memorial Building, University of Minnesota, Minneapolis, Minnesota 55455.

Diabetes Care 1983;6(1):101

https://doi.org/10.2337/diacare.6.1.101

PubMed:

6839918

Why Randomize in Clinical Trials?

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Why Randomize in Clinical Trials?

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only